Obstructive Sleep Apnea-OSA

The Relationship Between OSA and Mood Disorders, Cognitive Impairment

By

Tori Rodriguez, MA, LPC, AHC

Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.

Cardiovascular Risk in Pediatric Obstructive Sleep Apnea: What Do We Know?

By

Tori Rodriguez, MA, LPC, AHC

A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.

Sleep-Disordered Breathing: Imposing Challenges in Spinal Cord Injury

By

Suzanne Bujara

Poor sleep quality in patients with spinal cord injury contributes to adverse outcomes, including cardiovascular events and rehabilitation challenges.

Obstructive Sleep Apnea During the COVID-19 Pandemic: Increased Mortality Risk and Viral Spread

By

Jessica Nye, PhD

Researchers reviewed COVID-19 literature to determine the relationship between obstructive sleep apnea (OSA) and adverse COVID-19 outcomes.

Mild Cognitive Impairment Prevalence in Patients With Suspected OSA

By

Sheila Jacobs

A high prevalence of mild cognitive impairment has been reported in patients referred to sleep clinics for suspected obstructive sleep apnea.

Rising Trend of Obstructive Sleep Apnea in the Aging HIV Population

By

Sweta Gupta

Investigators assessed the incidence of obstructive sleep apnea in patients with HIV and the comorbidities associated with increased incidence.

Pitolisant as Adjunct Therapy to CPAP May Decrease Daytime Sleepiness in OSA

By

Sheila Jacobs

In patients with obstructive sleep apnea with residual sleepiness, the use of pitolisant as an adjunct to CPAP therapy significantly decreases subjective and objective sleepiness.

Poorer Clinical Outcomes From COVID-19 Seen in Patients With Obstructive Sleep Apnea

By

Jessica Nye, PhD

A review of relevant literature looked at the relationship between obstructive sleep apnea and adverse COVID-19 outcomes.